Mutations in the genes encoding AKT and mammalian target of rapamycin (mTOR), which are involved in the PI3K signalling pathway, are rare in cancers.123 However, mutant forms of these proteins can still contribute to cancer cell migration and invasion. This evidence concerns the gene MTOR and cancer.